The role of catecholamines in immune changes associated with the metabolic stress of 2-deoxy-D-glucose (2-DG) was examined in this study. Male Lewis rats were pretreated with the nonselective b-adrenergic receptor antagonist nadolol (0-0.5 mg/kg) and then received either a saline or 2-DG (500 mg/kg) injection. Nadolol attenuated the 2-DG-induced suppression of splenic T-cell mitogenic response and interferon-g production and increased nitric oxide production by macrophages in a dose-dependent manner. Conversely, nadolol did not attenuate the 2-DG-induced changes in immune parameters in peripheral blood leukocytes. These results suggest that the peripheral release of catecholamines is responsible for 2-DGinduced splenic immune alterations, whereas the peripheral release of catecholamine is not responsible for 2-DG-induced blood immune alterations. Furthermore, the neuroendocrine mechanisms responsible for splenic immune changes induced by the metabolic stress of 2-DG administration were the same as those involved in immune changes induced by physical and psychological stress. Thus, this study suggests that common neuroendocrine pathways exist for several types of stress-induced immunomodulations. ᭧ 1997 Academic Press
INTRODUCTION
The glucose analogue 2-deoxy-D-glucose (2-DG) induces metabolic stress by preventing cellular uptake and utilization of glucose. In rodent studies, acute administration of 2-DG inhibited splenic and blood T-cell proliferation induced by concanavalin A (Con A) and phytohemagglutinin (PHA) mitogens in Sprague-Dawley rats (Lysle et al., 1988) . Similar results were also observed in Swiss-Webster mice (Miller et al., 1994) .
Although the administration of 2-DG to Lewis rats produced suppression of T-cell proliferation after one injection, after multiple (five) injections the immune suppression of splenic T-cell responses was attenuated, but not the suppression of blood T-cell responses. In addition, production of IL-1 and IL-2 in peripheral blood cultures was significantly decreased, but not in spleen (Chou et al., 1996) . This finding suggests that different immune compartments are uniquely affected by stress and the regulation of the immune response in spleen and blood is mediated by different mechanisms.
The mechanisms by which 2-DG exerts immune suppressive effects are still unclear. Although 2-DG can affect intracellular glucose metabolism, it is unlikely that changes in immune function are a direct effect of 2-DG. In vitro incubation of naive T-cells with varying concentrations of 2-DG did not result in a reduction in cell number or viability (Miller et al., 1994 ).
An interaction among the immune, nervous, and endocrine systems is most com-
